Intermittent Hormone Therapy for Prostate Cancer 101 | Ask a Prostate Expert, Mark Scholz, MD

How Much Time Do You Have to Treat #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRI

Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

How to Read MRI Scans | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer

Rising PSA After Radiation For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRI

New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRI

How BPH Complicates Treatment for Prostate Cancer | Mark Scholz, MD | PCRI

PSA After Radiation | Ask a Prostate Expert, Mark Scholz, MD

Understanding PSA, PIRADS, Tumor Size, & Location | Answering YouTube Comments #59 | Mark Scholz, MD

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRI

Low Gleason Score (6 or 7) + High PSA? | Prostate Cancer | Mark Scholz, MD | PCRI

Beam Radiation Vs. Brachytherapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MD

IMRT vs. SBRT & Reducing Radiation Toxicity | #MarkScholzMD #AlexScholz #PCRI

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRI

Treatment for Few Metastases | Oligo-Metastases Disease | Mark Scholz, MD | PCRI

Orgovyx: New FDA Approved Hormone Therapy | 2020: The Year In Review | Mark Scholz, MD

Enlarged Prostate (BPH) Vs. Prostate Cancer | Mark Scholz, MD | PCRI

Is Prostate Cancer Fatal? | Ask A Prostate Expert, Mark Scholz, MD

A Medical Oncologist Compares Surgery and Radiation for Prostate Cancer | Mark Scholz, MD | PCRI

Treatment Strategies for Gleason 3+4=7 vs. 4+3=7 | Ask a Prostate Cancer Expert, Mark Scholz, MD

Ivermectin, Mebendazole, & Prostate Cancer? |#MarkScholzMD #MarkMoyadMD #PCRI

Is Seminal Vesicle Invasion Considered Metastatic Disease? | Mark Scholz, MD | PCRI

Inconclusive Prostate MRIs, Targeted Biopsy, Second Opinions for Pathology | Mark Scholz, MD | PCRI

Radiation Therapy: Long Term & Short Term Side Effects #ProstateCancer | #MarkScholzMD #AlexScholz

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRI

What is Cyberknife and How Does it Work? | Ask A Prostate Expert, Mark Scholz, MD

Can Targeted Biopsies Replace Random 12-Core Biopsies? | Answering YouTube Comments #34 | Dr. Scholz

PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD

Old vs. New Prostate Cancer Imaging | Ask a Prostate Expert, Mark Scholz, MD

Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRI

Your Overall Health Matters as Much as Your Prostate Cancer Care | Mark Moyad, MD & Mark Scholz, MD

Why Doctors Don't Talk About Brachytherapy | Ask a Prostate Expert, Mark Scholz, MD

Prostate Cancer Mortality Rate Explained | Answering YouTube Comments #48 | Mark Scholz, MD | PCRI